[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368223-105":59,"doc-detail-368223-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","correlation-of-cumulative-fasting-blood-glucose-exposure-with-gastrointestinal-cancers-a-prospective-cohort-study","Correlation of Cumulative Fasting Blood Glucose Exposure with Gastrointestinal Cancers - A Prospective Cohort Study","","A prospective cohort study assessed how cumulative fasting blood glucose exposure (cumFPG) relates to digestive malignancies while accounting for the competing risk of death, which may bias traditional cohort estimates. Data from 53,747 participants completing three consecutive examinations since 2006 were analyzed using Cox and competing-risk models. Sensitivity excluded cancers within 5 years and users of hypoglycemic drugs. Over 10.58 years, 817 gastrointestinal cases emerged; higher cumFPG (Q2–Q4) showed increasing incidence risk, especially for colorectal, liver, and pancreatic cancers. Restricted cubic spline analysis indicated an inverted “√” pattern, suggesting high cumFPG as an independent risk factor and potential prevention target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/correlation-of-cumulative-fasting-blood-glucose-exposure-with-gastrointestinal-cancers-a-prospective-cohort-study/368223/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/correlation-of-cumulative-fasting-blood-glucose-exposure-with-gastrointestinal-cancers-a-prospective-cohort-study/368223.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-21","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study question regarding cumFPG and digestive malignancies?","Question",{"text":112,"@type":113},"The study evaluated the association between cumulative fasting blood glucose exposure (cumFPG) and malignant tumors of the digestive system, while considering the competing risk of death.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants and cumFPG exposure classified?",{"text":117,"@type":113},"A total of 53,747 participants with three consecutive physical examinations since 2006 were included, and cumFPG was divided into four groups based on quartiles.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about the relationship between cumFPG and gastrointestinal cancer risk?",{"text":121,"@type":113},"Higher cumFPG groups (Q2–Q4) showed sequentially increased incidence risk versus Q1 in Cox models, with stronger effects observed for colorectal, liver, and pancreatic cancers. Restricted cubic spline results indicated an inverted “√” type association.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368223,1790861578,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","®  \n Observational Study   \nCorrelation of cumulative fasting blood glucose exposure with gastrointestinal cancers A prospective cohort study  \nKuan Liu, MMa , Wanchao Wang, MMa , Ye Liu, MMb , Jiaxing Li, MMa , Chao Ma, MMa , Yuan Tian, MMa , Zhigang Dong, MBa , Lichao Zhu, MMc , Wenqiang Wei, MMa , Minqiang Ren, MMa , Shouling Wu, MDd , Siqing Liu, MMa ,*  \n\n| Abstract\u003Cbr>At present, there is a lack of research on the correlation between cumFPG and digestive malignancies, and previous cohort studies have not considered the competitive risk between death and digestive malignancies, which may overestimate the impact of related risk factors. To explore the correlation between cumFPG and malignant tumors of the digestive system. In this study, 53,747 participants who had undergone 3 consecutive physical examinations since 2006 were collected. Finally, a total of 53,747 participants were included in this study. According to the grouping method of previous studies, cumFPG was divided into 4 groups according to the quartile. Cox regression model and competitive risk model were used to assess the risk of new digestive system malignancy. In sensitivity analyses, participants with cancer within 5 years of follow-up were excluded to eliminate the possibility of reverse causation. Subjects taking hypoglycemic drugs were excluded to eliminate the effect of the drug on blood glucose. Restricted cubic splineregresion (RCS) was then used to calculate the relationship between cumFPG and GI cancers. The mean age of participants was 49.02 ± 11.78 years. During a mean follow-up of 10.58 years, 817 new Gastrointestinal cases were identified, and the Cox proportional hazards model suggested that the risk of incidence in the Q2 to Q4 group increased sequentially compared with the lowest Q1 group, even after excluding the diagnosis of digestive malignancy within 5 years, the participants taking hypoglycemic drugs, and the death competition risk model analysis. In site-specific analysis, we observed that this risk was more pronounced in colorectal cancer, liver cancer, and pancreatic cancer, while gastric cancer, small bowel cancer, and bile duct cancer all had a similar trend to the main model but were not statistically significant, while esophageal cancer was U-shaped but not statistically significant. RCS results showed that cumFPG was associated with a similar risk of digestive system tumors, showing an inverted “√” type relationship. High levels of cumFPG are an independent factor in malignancy of the digestive system. cumFPG can provide a new idea for the prevention of Gastrointestinal cancers. |\n| --- |\n| Abbreviations: ANOVA = analysis of variance, BMI = body mass index, CI = confidence interval , CRP = c-reactive protein, CS = sub-distribution hazard function model, cumFPG = cumulative fasting blood glucose, DM = Diabetes Mellitus, EDTA = ethylene diamine tetraacetic acid, FPG = fasting blood glucose, GI = gastrointestinal, HBV = hepatitis B virus, HR = hazard ratio, NAFLD = nonalcoholic fatty liver disease, RCS = restricted cubic splineregresion, SD = cause-specific hazard model, T1DM = type 1 diabetes mellitus, TG = triglyceride. |\n| Keywords: cohort studies, Competitive risk model, cumFPG, GI cancers, risk factors |\n\n1. Introduction  \nAccording to global cancer statistics 2023, 3 of the top 5 cancer types that cause death are malignancies of the digestive system,  \nincluding colorectal cancer (9%), pancreatic cancer (8%), and liver cancer (6%).[1] In China, liver cancer is the second leading cause of cancer death, followed by gastric cancer, esophageal  \nKL, WW, and YL contributed equally to this work as well as SL and SW contributed equally to this paper.  \nThe authors have no funding and conflicts of interest to disclose. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.  \nThis study was approved by the Medical Ethics Committee of Kailuan General Ho","cbCaihOEZuTa4lXY","https://ap.wps.com/l/cbCaihOEZuTa4lXY","pdf",683142,"English","# Introduction\n## Background and significance\n# Methods\n## Study population and follow-up\n## Statistical analysis (Cox and competing-risk models)\n## Sensitivity analyses\n## Restricted cubic spline regression\n# Results\n## Main findings\n## Site-specific findings\n## Dose-response relationship\n# Discussion\n## Interpretation and implications for prevention","[{\"question\":\"What was the study question regarding cumFPG and digestive malignancies?\",\"answer\":\"The study evaluated the association between cumulative fasting blood glucose exposure (cumFPG) and malignant tumors of the digestive system, while considering the competing risk of death.\"},{\"question\":\"How were participants and cumFPG exposure classified?\",\"answer\":\"A total of 53,747 participants with three consecutive physical examinations since 2006 were included, and cumFPG was divided into four groups based on quartiles.\"},{\"question\":\"What did the study find about the relationship between cumFPG and gastrointestinal cancer risk?\",\"answer\":\"Higher cumFPG groups (Q2–Q4) showed sequentially increased incidence risk versus Q1 in Cox models, with stronger effects observed for colorectal, liver, and pancreatic cancers. Restricted cubic spline results indicated an inverted “√” type association.\"}]","Correlation of Cumulative Fasting Blood Glucose Exposure with Gastrointestinal Cancers - A Prospective Cohort Study | PDF",1790175746,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/763a747350ab5e1c5dbfb7475180b234.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51a14d007b9f86ff4e530e516c344063.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c408a6802ae62ef3d59b87bf4cd59cf3.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3f6c042847055ea5d3829510aacf0ca.webp",980,1306]